What is the recommended approach to diagnose and manage hyponatremia, including acute symptomatic cases, chronic cases, and the different volume statuses (hypovolemic, euvolemic, hypervolemic)?

Diagnosis and Management of Hyponatremia

Initial Diagnostic Workup

Begin by confirming true hypotonic hyponatremia through serum osmolality (<275 mOsm/kg) and exclude pseudohyponatremia from hyperglycemia by adding 1.6 mEq/L to measured sodium for each 100 mg/dL glucose above 100 mg/dL. 1, 2

Essential initial laboratory tests include:

• Serum osmolality, urine osmolality, and urine sodium concentration to determine the underlying mechanism 1
• Serum creatinine and blood urea nitrogen to assess renal function 1
• Thyroid-stimulating hormone (TSH) to exclude hypothyroidism 1
• Morning cortisol level to rule out adrenal insufficiency 1
• Serum uric acid (values <4 mg/dL have 73-100% positive predictive value for SIADH) 1

Do not order plasma ADH or natriuretic peptide levels—these tests are not supported by evidence, delay diagnosis, and do not alter management. 1

---

Volume Status Assessment

Physical examination alone is unreliable for determining volume status (sensitivity 41%, specificity 80%), so laboratory parameters must guide your assessment. 1

Hypovolemic Signs

• Orthostatic hypotension, tachycardia 1
• Dry mucous membranes, decreased skin turgor 1
• Flat neck veins 1
• Urine sodium <30 mmol/L (71-100% positive predictive value for saline responsiveness) 1

Euvolemic Signs

• Normal blood pressure, no edema 1
• Moist mucous membranes 1
• Urine sodium >20-40 mmol/L with urine osmolality >300 mOsm/kg suggests SIADH 1

Hypervolemic Signs

• Peripheral edema, ascites 1
• Jugular venous distention 1
• Pulmonary congestion 1

---

Management Based on Symptom Severity

Severe Symptomatic Hyponatremia (Medical Emergency)

Severe symptoms include altered mental status, seizures, coma, or respiratory distress—this requires immediate intervention with 3% hypertonic saline. 1, 2, 3

Administer 100 mL boluses of 3% hypertonic saline intravenously over 10 minutes, repeatable up to three times at 10-minute intervals. 1, 2

Target correction of 6 mmol/L over the first 6 hours or until severe symptoms resolve, but never exceed 8 mmol/L total correction in any 24-hour period. 1, 2, 4

Monitor serum sodium every 2 hours during initial correction. 1, 2

Moderate Symptomatic Hyponatremia

Symptoms include nausea, vomiting, headache, confusion, or gait instability 5, 3

• For sodium 120-125 mmol/L with moderate symptoms: Implement fluid restriction to 1-1.5 L/day and discontinue diuretics 1, 2
• Monitor serum sodium every 4-6 hours 1

Asymptomatic or Mild Hyponatremia

Even mild hyponatremia (130-135 mmol/L) is not benign—it increases fall risk 4-fold (21% vs 5%) and carries a 60-fold increased mortality risk when sodium <130 mmol/L (11.2% vs 0.19%). 1, 5

• For sodium 126-135 mmol/L: Continue current therapy with close electrolyte monitoring 1, 2
• For sodium <125 mmol/L: Stop diuretics and implement volume-status-specific treatment 1, 2

---

Management Based on Volume Status

Hypovolemic Hyponatremia

Discontinue diuretics immediately and administer isotonic (0.9%) saline for volume repletion. 1, 2

• Initial infusion rate: 15-20 mL/kg/h, then 4-14 mL/kg/h based on clinical response 1
• Continue until clinical euvolemia is achieved (resolution of orthostatic hypotension, improved skin turgor, urine sodium <30 mmol/L) 1
• Avoid hypotonic fluids (0.45% saline, lactated Ringer's, D5W) as they worsen hyponatremia 1

Euvolemic Hyponatremia (SIADH)

Fluid restriction to 1 L/day (or <800 mL/day for refractory cases) is the cornerstone of treatment. 1, 2

If fluid restriction fails after 48 hours:

• Add oral sodium chloride 100 mEq three times daily 1
• Consider vasopressin receptor antagonists (tolvaptan 15 mg once daily, titrate to 30-60 mg) for resistant cases 1
• Alternative pharmacologic options: urea, loop diuretics, demeclocycline, or lithium 1

Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)

Implement fluid restriction to 1-1.5 L/day for serum sodium <125 mmol/L and treat the underlying condition. 1, 2

For cirrhotic patients:

• Discontinue diuretics temporarily if sodium <125 mmol/L 1
• Consider albumin infusion (8 g per liter of ascites removed) alongside fluid restriction 1
• Avoid hypertonic saline unless life-threatening symptoms are present—it worsens ascites and edema 1

For heart failure patients:

• Continue diuretics at reduced doses while monitoring sodium closely—persistent volume overload worsens outcomes 1
• Optimize guideline-directed medical therapy (ACE inhibitors, beta-blockers, aldosterone antagonists) before adding adjunctive hyponatremia treatments 1

---

Critical Correction Rate Guidelines

Standard-risk patients: Maximum correction of 8 mmol/L in any 24-hour period (target 4-8 mmol/L per day). 1, 2, 4

High-risk patients (advanced liver disease, chronic alcoholism, malnutrition, prior encephalopathy): Maximum correction of 4-6 mmol/L per day, absolute ceiling of 8 mmol/L in 24 hours. 1, 2, 4

Exceeding these limits risks osmotic demyelination syndrome—a devastating complication causing dysarthria, dysphagia, oculomotor dysfunction, quadriparesis, or death, typically appearing 2-7 days after overcorrection. 1, 4

---

Special Populations and Pitfalls

Neurosurgical Patients

Distinguish cerebral salt wasting (CSW) from SIADH—they require opposite treatments. 1, 6

CSW characteristics:

• True hypovolemia (orthostatic hypotension, CVP <6 cm H₂O) 1
• Urine sodium >20 mmol/L despite volume depletion 1
• Treatment: Aggressive volume and sodium replacement with isotonic or hypertonic saline, fludrocortisone 0.1-0.2 mg daily 1
• Never use fluid restriction in CSW—it worsens outcomes and can precipitate cerebral ischemia 1, 6

In subarachnoid hemorrhage patients at risk of vasospasm:

• Avoid fluid restriction 1
• Consider fludrocortisone or hydrocortisone to prevent natriuresis 1

Cirrhotic Patients

Hyponatremia in cirrhosis (sodium ≤130 mmol/L) increases risk of:

• Spontaneous bacterial peritonitis (OR 3.40) 1, 2
• Hepatorenal syndrome (OR 3.45) 1, 2
• Hepatic encephalopathy (OR 2.36) 1, 2

These patients require exceptionally cautious correction (4-6 mmol/L per day maximum) due to 0.5-1.5% risk of osmotic demyelination syndrome even with careful management. 1

---

Management of Overcorrection

If sodium correction exceeds 8 mmol/L in 24 hours:

1. Immediately discontinue current fluids and switch to D5W (5% dextrose in water) 1, 2
2. Administer desmopressin to slow or reverse the rapid rise 1, 2
3. Target reduction to bring total 24-hour correction back to ≤8 mmol/L from baseline 1
4. Monitor for osmotic demyelination syndrome signs over the next 2-7 days 1

---

Common Pitfalls to Avoid

• Ignoring mild hyponatremia (130-135 mmol/L) as clinically insignificant—even mild chronic hyponatremia causes cognitive impairment, falls, and increased mortality 1, 5, 7
• Using fluid restriction in cerebral salt wasting—this is potentially fatal 1, 6
• Applying fluid restriction in subarachnoid hemorrhage patients at risk of vasospasm—this increases ischemic complications 1
• Correcting chronic hyponatremia faster than 8 mmol/L in 24 hours—this causes osmotic demyelination syndrome 1, 4
• Using hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms—this worsens fluid overload 1
• Stopping diuretics prematurely in heart failure due to mild hyponatremia—persistent volume overload is more dangerous 1
• Relying on physical examination alone for volume assessment—laboratory parameters are essential 1